NFKB1 and chronic obstructive pulmonary disease: Its ability to block the NF-κB pathway has been harnessed to inhibit the development of abdominal aortic aneurysm (Liang et al., 2017) and chronic pulmonary obstructive disease (COPD) (Li et al., 2020).